Atrial fibrillation in chronic kidney disease - treatment standard
Nephrology Dialysis Transplantation · 13.11.2026
DOI: 10.1093/ndt/gfag263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 13.11.2026. Verfasst von Caroline Schneppe und 6 weiteren Autor:innen. Beteiligte Einrichtung: AGAPLESION MARKUS KRANKENHAUS, Department of Nephrology, Hypertension and Vascular Diseases, Frankfurt, Germany.
Abstract (Originalsprache)
The prevalence of atrial fibrillation (AF) is high among patients with chronic kidney disease (CKD). While patients with CKD Stages G1 – G3b may be treated similarly to patients without CKD, little evidence guides therapeutic strategies for CKD G4 - G5 patients. Dosing of most drugs used for rate and rhythm control requires adjustment to kidney function. Recurrence rates after cardioversion and ablation for rhythm control are higher in patients with advanced CKD than those without it. Regarding the prevention of stroke and systemic embolism, the benefit-to-risk ratio of oral anticoagulation (OAC) is disputed among patients with CKD stages G4 - G5 with AF, in particular among those receiving hemodialysis given their high risk for severe bleeding events. Novel strategies for stroke and systemic embolism prevention, particularly factor XI inhibitors and left atrial appendage occlusion (LAAO), have not yet fulfilled their initial promise as safe and effective alternatives.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AGAPLESION MARKUS KRANKENHAUS, Department of Nephrology, Hypertension and Vascular Diseases, Frankfurt, Germany.
- Saarland University, Saarbrücken, Germany.
- KfH Kuratorium für Dialyse und Nierentransplantation, Neu-Isenburg, Germany.
- University Heart Center Lübeck, Medical Clinic II (Cardiology-Angiology-Intensive Care Medicine), Lübeck, Germany.
- Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm.
- Department of Nephrology, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Marie Evans, Wolfgang Winkelmayer, An S De Vriese
Zitieren
APA
Schneppe, C., Heine, G. H., Eitel, I., Evans, M., Urbanek, L., Winkelmayer, W., & De Vriese, A. S. (2026). Atrial fibrillation in chronic kidney disease - treatment standard. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfag263
Vancouver
Schneppe C, Heine GH, Eitel I, Evans M, Urbanek L, Winkelmayer W, et al. Atrial fibrillation in chronic kidney disease - treatment standard. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfag263
BibTeX
@article{Schneppe2026,
author = {Schneppe, Caroline and Heine, Gunnar H and Eitel, Ingo and Evans, Marie and Urbanek, Lukas and Winkelmayer, Wolfgang and De Vriese, An S},
title = {Atrial fibrillation in chronic kidney disease - treatment standard},
journal = {Nephrology Dialysis Transplantation},
year = {2026},
doi = {10.1093/ndt/gfag263}
}
EUVIMED